JAMA Drug Pricing Studies: Moving The Needle Or Looking At The Past?
Executive Summary
Studies show net prices increases, R&D spending lower than often cited, and better profit margins other industries. But pharma pushes back with concerns about study designs and maintains the picture has changed in more recent years.